BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19913617)

  • 21. Fasudil attenuates lipopolysaccharide-induced acute lung injury in mice through the Rho/Rho kinase pathway.
    Li Y; Wu Y; Wang Z; Zhang XH; Wu WK
    Med Sci Monit; 2010 Apr; 16(4):BR112-118. PubMed ID: 20357711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of rat spinal cord injury with a Rho-kinase inhibitor and bone marrow stromal cell transplantation.
    Furuya T; Hashimoto M; Koda M; Okawa A; Murata A; Takahashi K; Yamashita T; Yamazaki M
    Brain Res; 2009 Oct; 1295():192-202. PubMed ID: 19651108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rho-Associated Protein Kinase-1 Mediates the Regulation of Inflammatory Markers in Diabetic Retina and in Retinal Müller Cells.
    Mohammad G; AlSharif HM; Siddiquei MM; Ahmad A; Alam K; Abu El-Asrar AM
    Ann Clin Lab Sci; 2018 Mar; 48(2):137-145. PubMed ID: 29678838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fasudil reduces GFAP expression after hypoxic injury.
    Kesherwani V; Tarang S; Barnes R; Agrawal SK
    Neurosci Lett; 2014 Jul; 576():45-50. PubMed ID: 24905175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rho kinase inhibition by fasudil attenuates cyclosporine-induced kidney injury.
    Park JW; Park CH; Kim IJ; Bae EH; Ma SK; Lee JU; Kim SW
    J Pharmacol Exp Ther; 2011 Jul; 338(1):271-9. PubMed ID: 21474569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fasudil, an inhibitor of Rho-associated coiled-coil kinase, attenuates hyperoxia-induced pulmonary fibrosis in neonatal rats.
    Qi XJ; Ning W; Xu F; Dang HX; Fang F; Li J
    Int J Clin Exp Pathol; 2015; 8(10):12140-50. PubMed ID: 26722398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses 5-hydroxytryptamine-induced pulmonary artery smooth muscle cell proliferation via JNK and ERK1/2 pathway.
    Chen XY; Dun JN; Miao QF; Zhang YJ
    Pharmacology; 2009; 83(2):67-79. PubMed ID: 19052484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Rho-associated kinase inhibitor fasudil hydrochloride enhances neural regeneration after axotomy in the peripheral nervous system.
    Madura T; Kubo T; Tanag M; Matsuda K; Tomita K; Yano K; Hosokawa K
    Plast Reconstr Surg; 2007 Feb; 119(2):526-35. PubMed ID: 17230085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Rho kinase inhibitor Fasudil up-regulates astrocytic glutamate transport subsequent to actin remodelling in murine cultured astrocytes.
    Lau CL; O'Shea RD; Broberg BV; Bischof L; Beart PM
    Br J Pharmacol; 2011 Jun; 163(3):533-45. PubMed ID: 21309758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fasudil prevents calcium oxalate crystal deposit and renal fibrogenesis in glyoxylate-induced nephrolithic mice.
    Hu H; Chen W; Ding J; Jia M; Yin J; Guo Z
    Exp Mol Pathol; 2015 Apr; 98(2):277-85. PubMed ID: 25697583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ROCK Inhibitor Fasudil Prevents Chronic Restraint Stress-Induced Depressive-Like Behaviors and Dendritic Spine Loss in Rat Hippocampus.
    García-Rojo G; Fresno C; Vilches N; Díaz-Véliz G; Mora S; Aguayo F; Pacheco A; Parra-Fiedler N; Parra CS; Rojas PS; Tejos M; Aliaga E; Fiedler JL
    Int J Neuropsychopharmacol; 2017 Apr; 20(4):336-345. PubMed ID: 27927737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rho-kinase inhibitor, fasudil, suppresses glioblastoma cell line progression in vitro and in vivo.
    Deng L; Li G; Li R; Liu Q; He Q; Zhang J
    Cancer Biol Ther; 2010 Jun; 9(11):875-84. PubMed ID: 20364104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of Fasudil in preclinical models of pain.
    Boyce-Rustay JM; Simler GH; McGaraughty S; Chu KL; Wensink EJ; Vasudevan A; Honore P
    J Pain; 2010 Oct; 11(10):941-9. PubMed ID: 20338818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of Rho-kinase attenuates nephrosclerosis and improves survival in salt-loaded spontaneously hypertensive stroke-prone rats.
    Nishikimi T; Koshikawa S; Ishikawa Y; Akimoto K; Inaba C; Ishimura K; Ono H; Matsuoka H
    J Hypertens; 2007 May; 25(5):1053-63. PubMed ID: 17414670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic effects of bone marrow stromal cells and a Rho kinase (ROCK) inhibitor, fasudil on axon regeneration in rat spinal cord injury.
    Chiba Y; Kuroda S; Shichinohe H; Hokari M; Osanai T; Maruichi K; Yano S; Hida K; Iwasaki Y
    Neuropathology; 2010 Jun; 30(3):241-50. PubMed ID: 19925560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic and Superimposed Effect of Bone Marrow-Derived Mesenchymal Stem Cells Combined with Fasudil in Experimental Autoimmune Encephalomyelitis.
    Yu JW; Li YH; Song GB; Yu JZ; Liu CY; Liu JC; Zhang HF; Yang WF; Wang Q; Yan YP; Xiao BG; Ma CG
    J Mol Neurosci; 2016 Dec; 60(4):486-497. PubMed ID: 27573128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ROCK inhibition with fasudil promotes early functional recovery of spinal cord injury in rats by enhancing microglia phagocytosis.
    Fu PC; Tang RH; Wan Y; Xie MJ; Wang W; Luo X; Yu ZY
    J Huazhong Univ Sci Technolog Med Sci; 2016 Feb; 36(1):31-36. PubMed ID: 26838736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effect of fasudil, a Rho-kinase inhibitor, on chemokine expression, leukocyte recruitment, and hepatocellular apoptosis in septic liver injury.
    Thorlacius K; Slotta JE; Laschke MW; Wang Y; Menger MD; Jeppsson B; Thorlacius H
    J Leukoc Biol; 2006 May; 79(5):923-31. PubMed ID: 16641138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistent migration of neuroblasts from the subventricular zone to the injured striatum mediated by osteopontin following intracerebral hemorrhage.
    Yan YP; Lang BT; Vemuganti R; Dempsey RJ
    J Neurochem; 2009 Jun; 109(6):1624-35. PubMed ID: 19457159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Rho kinase (ROCK) inhibitor, fasudil, prevents matrix metalloproteinase-9-related hemorrhagic transformation in mice treated with tissue plasminogen activator.
    Ishiguro M; Kawasaki K; Suzuki Y; Ishizuka F; Mishiro K; Egashira Y; Ikegaki I; Tsuruma K; Shimazawa M; Yoshimura S; Iwama T; Hara H
    Neuroscience; 2012 Sep; 220():302-12. PubMed ID: 22710066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.